Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Sarcopenia is a progressive disease with age-related loss of skeletal muscle mass, strength, and function. No study has investigated the association between healthy beverage index (HBI) and sarcopenia in older adults. Therefore, the present study aimed to investigate the association between HBI and sarcopenia in Iranian older adults.
Methods: In the present case-control study, 80 sarcopenic and 80 non-sarcopenic participants matched in sex were included. Body composition was measured using bioelectrical impedance analysis. Handgrip strength (HGS), skeletal muscle mass index (SMI), and gait speed were utilized to confirm sarcopenia. Also, a food frequency questionnaire was used to evaluate food intake. HBI score was calculated based on ten sub-components of the total beverages. Moreover, logistic regression was applied to assess the association between HBI and sarcopenia.
Results: In the crude model, we observed no significant association between HBI and the odds of sarcopenia. Still, after adjusting the confounders, the odds of developing sarcopenia decreased significantly in the second and last tertiles (T) (T- odds ratio (OR) = 0.04, 95% confidence interval (CI): 0.01-0.25 and T- OR = 0.10, 95% CI: 0.01-0.60).
Conclusions: Our findings indicated that HBI is inversely related to the chance of sarcopenia. Therefore, to reduce the odds of sarcopenia, it is recommended to consume healthy drinks such as fruit juices and milk.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10929141 | PMC |
| http://dx.doi.org/10.1186/s12877-024-04790-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An exploratory single-cell analysis of peripheral blood mononuclear cells from vedolizumab-treated Crohn's disease patients identifies response-associated differences among the plasmacytoid dendritic cells and classical monocytes.
Front Immunol
September 2025
Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.
Background: Vedolizumab (VDZ) is a monoclonal antibody approved for the treatment of Crohn's disease (CD). Despite its efficacy, non-response to VDZ is common in clinical practice with no clear understanding of how it manifests. Here, we performed an exploratory study characterizing the cellular repertoire of responders and non-responders to VDZ during treatment.
View Article and Find Full Text PDFAssociations of the Healthy Beverage Index and the risk of colorectal cancer: a case-control study.
Front Nutr
August 2025
Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Background: Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide. Emerging evidence suggests that dietary patterns can significantly influence CRC risk, with beverages playing a critical role. The Healthy Beverage Index (HBI) is a tool to assess the healthfulness of beverage consumption, yet its relationship with colorectal cancer risk has not been extensively studied.
View Article and Find Full Text PDFQuality of life among patients with multiple sclerosis: association with disease acceptance, optimism, and health-promoting behaviors.
Sci Rep
August 2025
Department of Neurology, Wroclaw Medical University, Wrocław, Poland.
Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system, primarily affecting individuals in early adulthood and serving as a leading cause of disability among young adults. Despite advancements in understanding its etiology, there is currently no cure for MS. The disease's unpredictability, progression, and associated symptoms can significantly impair patients' daily, familial, social, and professional functioning, thereby substantially diminishing their quality of life.
View Article and Find Full Text PDFAdherence to a Mediterranean dietary pattern is associated with biochemical remission in patients with Crohn's disease.
Clin Nutr
August 2025
Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel; Department of Health Promotion, School of Public Health, Gray School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Background: The Mediterranean Diet (MD) was recently found to have benefits for patients with Crohn's Disease (CD) in various stages of the disease, though adherence to it may be limited during active disease. We aimed to evaluate the association between adherence to the MD and changes in fecal calprotectin (FC) levels among patients with CD in clinical and biochemical remission.
Methods: A prospective cohort of patients with CD in clinical and biochemical remission [Harvey-Bradshaw Index (HBI) < 5 and FC < 250 μg/g].
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.
J Clin Gastroenterol
August 2025
Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France; Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 2018, Clermont-Ferrand, France.
Goals: We assessed clinical outcomes over 6 months in an integrated analysis of inflammatory bowel disease (IBD) patients switching from intravenous (IV) to subcutaneous (SC) infliximab (IFX).
Background: Real-world data from large multinational IBD patient populations treated with SC IFX are lacking.
Study: This individual participant data meta-analysis combined anonymized data from 3 real-world cohorts and evaluated clinical remission [Crohn's disease (CD): Harvey-Bradshaw Index (HBI)/modified HBI (mHBI) <5; ulcerative colitis (UC): Simple Clinical Colitis Activity Index (SCCAI)/partial Mayo score (PMS) <3], disease activity (HBI/mHBI/SCCAI/PMS), treatment persistence, pharmacokinetics, immunogenicity, biomarkers [fecal calprotectin (FCP); C-reactive protein (CRP)], and reasons for discontinuation.